National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
March 23, 2010 • Volume 7 / Number 6


I-SPY2 trial logoI-SPY2: Breast Cancer Trial Aims to Speed Drugs to the Clinic

On March 17, the Foundation for the National Institutes of Health and its Biomarkers Consortium announced the launch of the I-SPY2 breast cancer clinical trial, a novel, adaptive clinical study designed to move promising new drugs into phase III clinical trials more quickly and cost effectively than traditional phase II studies. Read more > >


Drs. Ann O’Mara and Andrea DenicoffGuest Director's Update: Improving Delivery of Quality Cancer Care

by Dr. Ann O’Mara and Andrea Denicoff

During a recent meeting with NCI-funded investigators at Memorial Sloan-Kettering Cancer Center in New York, we saw an older gentleman sitting in the waiting room, his wife by his side, with a small tablet PC on his lap. He was, we learned, completing a questionnaire about any symptoms or side effects he was having from the treatment he was undergoing for metastatic prostate cancer. Read more > >

Guest Commentary by Dr. Andrea Barsevick: Fatigue—Is it Normal or Pathological? And How Can We Best Treat It?

Soon experts will meet to discuss state of the science and how research can move forward more efficiently Read more > >

A Conversation with Dr. Ann Berger on Palliative Care at NIH

The head of the Pain and Palliative Care Service talks about her work at the NIH Clinical Center Read more > >



A Look at Palliative Care

In this issue you will notice several articles related to the important topic of palliative care. For a list of NCI resources on this topic, look for the box at the end of the Guest Director’s Update.



  • Notes

    • Free Telephone Workshop Series for Cancer Survivors
    • Print Your Own Copies of Selected NCI Patient Education Booklets

Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at

Next Section >